how many people are taking glp 1 drugs GLP-1 Agonists Weight Loss Market Report, 2025-2030 GLP-1 use peaks in middle

This finding carries significant implications, given that type 2 diabetes is linked to an increased susceptibility to various types of cancer

Combined with mindful eating, exercise, adequate sleep, and avoiding sugary, ultra-processed foods, these strategies can help you maintain steady GLP-1 levels and support sustainable weight loss

approved for type 2 diabetes, with some formulations phased out over time

9 , 10 Many patients struggle to maintain the necessary behavioral changes long term, leading to modest results which are often inadequate in addressing the complex physiological, genetic, and environmental factors underlying obesity

For instance, in February 2024, the Ministry of Health, Canada, introduced Bill C-64 to establish universal pharmacare, covering diabetes drug such as insulin USD 900-USD 1,700/year, metformin ~USD 100/year, and adjunct therapies USD 100-USD 1,000+/year for type 1 and type 2 diabetes patients under single-payer insurance